Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients

Novartis malaria treatment Coartem® 80/480mg receives WHO prequalification, enabling greater access for patients WHO prequalified Coartem® 80/480mg is the first and only high strength malaria treatment available for donor-funded public sector procurement BALE, Switzerland July 16, 2015/African Press Organization (APO)/ — WHO prequalified Coartem® 80/480mg is the first and only high strength malaria treatment available […]http://feedproxy.google.com/~r/Appa-sourceTheAfric...